MoneyWorks4Me

Unjha Formulations - Quaterly Results

01 Aug 2024 Evaluate
The revenue for the June 2024 quarter is pegged at Rs. 39.54 millions, about 5.33% up against Rs. 37.54 millions recorded during the year-ago period.The Net Profit of the company vaulted to 283.52% to Rs. 6.98  millions from Rs. 1.82 millions in the previous quarter.The company reported a good operating profit of 7.21 millions compared to 2.05 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202406 202306 % Var 202406 202306 % Var 202403 202303 % Var
Sales 39.54 37.54 5.33 39.54 37.54 5.33 185.08 131.85 40.37
Other Income 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBIDT 7.21 2.05 251.71 7.21 2.05 251.71 5.89 4.63 27.21
Interest 0.01 0.04 -75.00 0.01 0.04 -75.00 0.56 0.58 -3.45
PBDT 7.20 2.01 258.21 7.20 2.01 258.21 5.33 4.05 31.60
Depreciation 0.22 0.19 15.79 0.22 0.19 15.79 0.81 0.77 5.19
PBT 6.98 1.82 283.52 6.98 1.82 283.52 4.52 3.28 37.80
TAX 0.00 0.00 0.00 0.00 0.00 0.00 1.74 0.47 270.21
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.06 0.00 0.00
PAT 6.98 1.82 283.52 6.98 1.82 283.52 2.78 2.81 -1.07
Equity 44.81 44.81 0.00 44.81 44.81 0.00 44.81 44.81 0.00
PBIDTM(%) 18.23 5.46 233.92 18.23 5.46 233.92 3.18 3.51 -9.37
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..